Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EQL Pharma AB ( (SE:EQL) ) has issued an announcement.
EQL Pharma’s Chief Commercial Officer, Alexander Brising, has sold shares worth approximately SEK 2.1 million to finance an apartment for his daughter attending university. Despite the sale, Brising remains committed to the company, holding 228,732 shares and emphasizing his belief in EQL Pharma’s future plans and developments.
More about EQL Pharma AB
EQL Pharma AB specializes in developing and selling generic drugs that are medically equivalent to original drugs. The company focuses on niche generics with limited competition and operates primarily in the Nordic and European markets. It collaborates with leading manufacturers and pharmaceutical companies in the EU and Asia and is listed on the Nasdaq Stockholm stock market.
YTD Price Performance: 3.46%
Average Trading Volume: 23,211
Technical Sentiment Signal: Buy
Current Market Cap: SEK2.44B
For detailed information about EQL stock, go to TipRanks’ Stock Analysis page.